Untested medicines and vaccines should be used to treat Ebola patients, the World Health Organisation has said, as the drugs could be 'potential asset' it was argued.
Experts have warned that using human Ebola victims for experiments was not ethical but after convening a panel of ethicists the WHO has agreed that untested drugs should be used.
Others have said it was unethical to withhold experimental treatments that could potentially help patients.
In a statement released by the WHO it stipulated that patients should give consent where possible to being treated with the drugs and all aspects of their care be transparent.
The panel was convened after an experimental drug called, ZMapp, made by American biotech company Mapp Biopharmaceutical, was given to two American health workers infected with Ebola in Liberia.
No comments:
Post a Comment